Kansas City Business Journal: 5 questions with Saint Luke's cardiologist that co-led groundbreaking new study

A new groundbreaking study found that in some situations invasive treatment, such as stents and bypass surgery, are no more effective than medication and lifestyle changes for preventing heart attacks or death in patients with heart disease.

The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches, or ISCHEMIA, has wide-reaching implications for how physicians will deliver individualized health care at the lowest possible risk and cost.

Dr. John Spertus, co-leader of the study and director of health outcomes research at Saint Luke's Mid America Heart Institute, talked to the Kansas City Business Journal about the study and how precision medicine will change the business of cardiology.

Read the full Kansas City Business Journal article: 5 questions with Saint Luke's cardiologist that co-led groundbreaking new study.

Dr. John Spertus, director of health outcomes research at Saint Luke's Mid America Heart Institute
Photo credit: Andrew Grumke, Kansas City Business Journal

Related Content

Saint Luke's cardiologist Dr. John Spertus
Dec. 1, 2019
KCUR: Saint Luke's Mid America Heart Institute lead researcher speaks to his role in groundbreaking international cardiology trial
A new groundbreaking study is helping cardiologists across the globe to better understand and provide the most suitable treatments for their patients. KCUR talks to Dr. John Spertus about the practice-changing trial.
doctor taking patients blood pressure
Nov. 18, 2019
Saint Luke’s Mid America Heart Institute is a major participant in international "practice-changing" clinical trial for patients with ischemic heart disease
ISCHEMIA trial outcomes found a significant benefit in quality of life and patient experience.

John A Spertus, MD

Cardiology